8/13/10

Oprah Co. Sued for Multiple Sclerosis Discrimination

(Posted By: Josi Creek)

A woman who worked for Oprah Winfrey's OWN network claims she was subjected to a hostile work environment  because she suffers from Multiple Sclerosis.
Read more »

Labels: discrimination

8/6/10

Clinical Trials Necessary to Approve a Copaxone Generic

(Posted By: Josi Creek)

Any generic of Teva’s blockbuster multiple sclerosis treatment Copaxone would need clinical trials to gain approval, the company says in response to speculation that the FDA might approve a generic Copaxone using the same criteria it applied to generic Lovenox. “In the case of Copaxone and other complex molecules, there are no acceptable … tests either in humans or animals that can be relied upon except for complete clinical tests, which reflect the clinical outcome in multiple sclerosis,” Teva CEO Shlomo Yanai said. 

Labels: Copaxone, Research, Studies

8/5/10

Investigators Recruiting Globally For Phase II Study Of Oral Multiple Sclerosis Pill

(Posted By: Josi Creek)

Investigators are recruiting 400 people with relapsing-remitting MS for a study evaluating three doses of ACT-128800, an oral compound that affects immune function, versus placebo. The study sponsor is Actelion Pharmaceuticals, Ltd. 
Read more »

Labels: Research, Studies

8/2/10

Novel multiple sclerosis theory (CCSVI) dealt a blow by studies

(Posted By: Josi Creek)

A novel theory about the cause of multiple sclerosis — one that quickly led to millions of dollars in research pledges and an increasingly popular, though unproved, treatment — took a hit Monday from two studies calling the premise into question.



Read more »

Labels: CCSVI, Research, Studies

Gene Variant May Increase Severity of Multiple Sclerosis

(Posted By: Josi Creek)

 A new study shows a gene variant may increase the severity of multiple sclerosis (MS) symptoms. The research will be published in the August 3, 2010, issue ofNeurology®, the medical journal of the American Academy of Neurology.
Read more »

Labels: genetics, Research, Studies

8/1/10

FDA Approves First Human Trial of Embryonic Stem Cells

(Posted By: Josi Creek)

The U.S. Food and Drug Administration approved the world’s first human clinical trial of a therapy involving embryonic stem cells, the biotechnology company behind the planned trial announced Friday.

Read more »

Labels: Research, Stem Cell, Studies

Multiple Sclerosis To Be Diagnosed Earlier – Study

(Posted By: Josi Creek)

UCI immunological study finds earlier way to diagnose multiple sclerosis (MS).

Assessing for the increasing presence of antibodies that blocks energy production in neurons, UCI immunologists discovered that it can be used also in diagnosing multiple sclerosis at an earlier stage of the disease than the usual diagnostic tools.

Read more »

Labels: Research, Studies